19-7647487-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006949.4(STXBP2):c.1672G>C(p.Glu558Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000138 in 1,452,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E558D) has been classified as Uncertain significance.
Frequency
Consequence
NM_006949.4 missense
Scores
Clinical Significance
Conservation
Publications
- familial hemophagocytic lymphohistiocytosis 5Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- hereditary hemophagocytic lymphohistiocytosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- microvillus inclusion diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006949.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STXBP2 | NM_006949.4 | MANE Select | c.1672G>C | p.Glu558Gln | missense | Exon 18 of 19 | NP_008880.2 | ||
| STXBP2 | NM_001272034.2 | c.1705G>C | p.Glu569Gln | missense | Exon 18 of 19 | NP_001258963.1 | |||
| STXBP2 | NM_001127396.3 | c.1663G>C | p.Glu555Gln | missense | Exon 18 of 19 | NP_001120868.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STXBP2 | ENST00000221283.10 | TSL:1 MANE Select | c.1672G>C | p.Glu558Gln | missense | Exon 18 of 19 | ENSP00000221283.4 | ||
| STXBP2 | ENST00000414284.6 | TSL:1 | c.1663G>C | p.Glu555Gln | missense | Exon 18 of 19 | ENSP00000409471.1 | ||
| STXBP2 | ENST00000597068.5 | TSL:1 | n.*420G>C | non_coding_transcript_exon | Exon 18 of 19 | ENSP00000471327.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452746Hom.: 0 Cov.: 76 AF XY: 0.00000138 AC XY: 1AN XY: 722242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial hemophagocytic lymphohistiocytosis 5 Uncertain:1
This sequence change replaces glutamic acid with glutamine at codon 558 of the STXBP2 protein (p.Glu558Gln). The glutamic acid residue is weakly conserved and there is a small physicochemical difference between glutamic acid and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with STXBP2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at